PDS Biotechnology Corp Earnings Per Share (Basic)
PDS Biotechnology Corp (PDSB) reported Earnings Per Share (Basic) of -$0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- PDS Biotechnology Corp earnings per share, basic for the quarter ending 2026-06-30 was -$0.18.
- PDS Biotechnology Corp earnings per share, basic for the quarter ending 2026-03-31 was -$0.13.
- PDS Biotechnology Corp earnings per share, basic for the quarter ending 2025-09-30 was -$0.19.
- PDS Biotechnology Corp earnings per share, basic for the quarter ending 2025-06-30 was -$0.21.
- PDS Biotechnology Corp earnings per share, basic for fiscal 2025 was -$0.74.
- PDS Biotechnology Corp earnings per share, basic for fiscal 2024 was -$1.03.
- PDS Biotechnology Corp earnings per share, basic for fiscal 2023 was -$1.39.
- PDS Biotechnology Corp earnings per share, basic for fiscal 2022 was -$1.43.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.18 10-Q · filed 2026-08-13 | -$0.31 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$0.13 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$0.74 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-13 | -$0.60 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | -$0.21 10-Q · filed 2026-08-13 | -$0.41 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$1.03 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$0.29 10-Q · filed 2025-11-13 | -$0.82 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$0.23 10-Q · filed 2025-08-13 | -$0.53 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$0.30 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$1.39 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$0.35 10-Q · filed 2024-11-14 | -$1.04 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$0.37 10-Q · filed 2024-08-13 | -$0.69 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$0.32 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$1.43 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$0.26 10-Q · filed 2023-11-14 | -$0.76 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$0.20 10-Q · filed 2023-08-14 | -$0.50 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.32 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$0.66 10-K · filed 2023-03-28 | |||
| 2021-09-30 | -$0.24 10-Q · filed 2022-11-14 | -$0.43 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$0.03 10-Q · filed 2022-08-08 | -$0.16 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.14 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | -$0.89 10-K · filed 2022-03-31 | |||
| 2020-09-30 | -$0.21 10-Q · filed 2021-11-10 | -$0.73 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$0.19 10-Q · filed 2021-08-12 | -$0.54 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$0.39 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |